Mar 04, 2024 / 02:10PM GMT
Daniel Gregory Brennan - TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
(technical difficulty) So I'm Dan Brennan, (technical difficulty) Prahlad Singh, President and CEO of Revvity. So Prahlad, welcome.
Prahlad R. Singh - Revvity, Inc. - CEO, President & Director
Thank you.
Daniel Gregory Brennan - TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
And thanks for coming. Listen, I will check my e-mail a couple of times throughout if any of you want to pose any questions. I'll see if I can weave those in. We have a list and a little over 30 minutes to tackle it.
Questions and Answers:
Daniel Gregory Brennan - TD Cowen, Research Division - MD and Senior Tools & Diagnostics AnalystSo maybe I thought just to kick it off, obviously, the long-term guide. You guys just took it down from 10% to 6% to 8%. You've got 75 to 100 basis points of EBIT expansion. You kind of tweaked that down to 75 basis points, still